ID26296A - SALT ADDITION OF ALORALOID MORPHIN AND ITS USE - Google Patents
SALT ADDITION OF ALORALOID MORPHIN AND ITS USEInfo
- Publication number
- ID26296A ID26296A IDW20000549A ID20000549A ID26296A ID 26296 A ID26296 A ID 26296A ID W20000549 A IDW20000549 A ID W20000549A ID 20000549 A ID20000549 A ID 20000549A ID 26296 A ID26296 A ID 26296A
- Authority
- ID
- Indonesia
- Prior art keywords
- substituted
- acids
- alternatively
- group
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
- C07D489/04—Salts; Organic complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
The invention relates to a material consisting of the acidic addition salt of a morphine alkaloid and an organic acid. The organic acid is selected from: monoesters of C3-C16 dicarboxylic acids with monovalent C1-C4 alcohols; C2-C16 sulphonic acids; substituted benzoic acids selected from the group of halogen-, hydroxy-, alkyl-, hydroxyalkyl-, alkoxy alkyl-, and/or alkoxy-substituted benzoic acids and the amino substituted benzoic acids alternatively alkylated on the N atom; 5 or 6 ring heterocycles with at least one N or S atom and one carboxyl groups function; saturated or unsaturated, alternatively substituted oxocarboxylic acids with 5 to 10 C atoms; phenyl- or phenoxy-substituted saturated C2-C4 carboxylic acid; aliphatic, aromatic or heterocyclic C2-C12 amino acids, wherein one amino group is substituted with an alternatively substituted C2-C6 alkanoyl group or an alternatively substituted benzoyl group.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19742296 | 1997-09-25 | ||
| DE19834005A DE19834005A1 (en) | 1997-09-25 | 1998-07-29 | Acid addition salts of morphine alkaloids and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID26296A true ID26296A (en) | 2000-12-14 |
Family
ID=26040297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20000549A ID26296A (en) | 1997-09-25 | 1998-09-05 | SALT ADDITION OF ALORALOID MORPHIN AND ITS USE |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1017696B1 (en) |
| JP (1) | JP2001517669A (en) |
| AT (1) | ATE214702T1 (en) |
| AU (1) | AU741434B2 (en) |
| CA (1) | CA2304722C (en) |
| CZ (1) | CZ300532B6 (en) |
| DK (1) | DK1017696T3 (en) |
| ES (1) | ES2174490T3 (en) |
| HU (1) | HUP0003686A3 (en) |
| ID (1) | ID26296A (en) |
| IL (1) | IL134787A (en) |
| MX (1) | MXPA00002658A (en) |
| NO (1) | NO20001465D0 (en) |
| NZ (1) | NZ503459A (en) |
| PL (1) | PL193321B1 (en) |
| PT (1) | PT1017696E (en) |
| SK (1) | SK4322000A3 (en) |
| TR (1) | TR200000653T2 (en) |
| TW (1) | TW576836B (en) |
| WO (1) | WO1999015528A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9924797D0 (en) | 1999-10-20 | 1999-12-22 | West Pharm Serv Drug Res Ltd | Compound |
| GB0218811D0 (en) * | 2002-08-14 | 2002-09-18 | Cenes Ltd | Salts of morphine-6-glucuronide |
| DE102006054732B4 (en) | 2006-11-21 | 2010-12-30 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system with ion-pair microreservoirs |
| WO2010016219A1 (en) * | 2008-08-05 | 2010-02-11 | 株式会社メドレックス | External preparation comprising fatty acid salt or benzoic acid salt of basic pharmacologically active component, and method for production thereof |
| US20130035488A1 (en) * | 2011-08-02 | 2013-02-07 | Mallinckrodt Llc | Stepwise Process for the Production of Alkaloid Salts |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE524639C (en) * | 1929-05-25 | 1931-05-09 | Chem Fab Vorm Sandoz | Process for the preparation of easily soluble salts of benzylmorphone |
| DE728804C (en) * | 1935-04-02 | 1942-12-03 | Jean Lucien Regnier | Process for the preparation of salts of morphine with aralkylcarboxylic acids |
| DE1172267B (en) * | 1961-09-19 | 1964-06-18 | Dausse S A Lab | Process for the preparation of the bis-guaiacol-sulfonic acid salt of morphine-ª ‰ -morpholyl-ethyl-ether |
| FR6598M (en) * | 1967-07-28 | 1969-01-06 | ||
| US4626539A (en) * | 1984-08-10 | 1986-12-02 | E. I. Dupont De Nemours And Company | Trandermal delivery of opioids |
| US4908389A (en) * | 1986-08-27 | 1990-03-13 | Warner-Lambert Company | Penetration enhancement system |
| US4879297A (en) * | 1987-06-01 | 1989-11-07 | Warner-Lambert Company | Fatty acids and their small chain esters as penetration enhancers in aqueous systems |
| US5374645A (en) * | 1990-01-22 | 1994-12-20 | Ciba-Geigy Corporation | Transdermal administation of ionic pharmaceutically active agents via aqueous isopropanol |
| TW225536B (en) * | 1990-08-23 | 1994-06-21 | Ciba Geigy Ag | |
| FR2708611B1 (en) * | 1993-07-29 | 1995-10-27 | Meram Lab | Codeine salt of 2- (3-benzoylphenyl) propionic acid, process for obtaining it and pharmaceutical compositions containing it. |
| DE19607395C2 (en) * | 1996-02-28 | 2002-11-21 | Lohmann Therapie Syst Lts | Salts from a cationic narcotic analgesic with an anionic non-narcotic analgesic, process for their preparation and the pharmaceutical preparations containing these salts |
-
1998
- 1998-09-05 PT PT98945312T patent/PT1017696E/en unknown
- 1998-09-05 MX MXPA00002658A patent/MXPA00002658A/en active IP Right Grant
- 1998-09-05 JP JP2000512833A patent/JP2001517669A/en active Pending
- 1998-09-05 EP EP98945312A patent/EP1017696B1/en not_active Expired - Lifetime
- 1998-09-05 HU HU0003686A patent/HUP0003686A3/en unknown
- 1998-09-05 AT AT98945312T patent/ATE214702T1/en active
- 1998-09-05 PL PL339516A patent/PL193321B1/en not_active IP Right Cessation
- 1998-09-05 WO PCT/EP1998/005652 patent/WO1999015528A1/en active IP Right Grant
- 1998-09-05 SK SK432-2000A patent/SK4322000A3/en unknown
- 1998-09-05 IL IL134787A patent/IL134787A/en not_active IP Right Cessation
- 1998-09-05 TR TR2000/00653T patent/TR200000653T2/en unknown
- 1998-09-05 CA CA002304722A patent/CA2304722C/en not_active Expired - Fee Related
- 1998-09-05 DK DK98945312T patent/DK1017696T3/en active
- 1998-09-05 NZ NZ503459A patent/NZ503459A/en not_active IP Right Cessation
- 1998-09-05 CZ CZ20001048A patent/CZ300532B6/en not_active IP Right Cessation
- 1998-09-05 ID IDW20000549A patent/ID26296A/en unknown
- 1998-09-05 AU AU92666/98A patent/AU741434B2/en not_active Ceased
- 1998-09-05 ES ES98945312T patent/ES2174490T3/en not_active Expired - Lifetime
- 1998-09-23 TW TW087115805A patent/TW576836B/en not_active IP Right Cessation
-
2000
- 2000-03-21 NO NO20001465A patent/NO20001465D0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE214702T1 (en) | 2002-04-15 |
| CZ20001048A3 (en) | 2000-08-16 |
| AU9266698A (en) | 1999-04-12 |
| SK4322000A3 (en) | 2000-10-09 |
| HUP0003686A2 (en) | 2001-09-28 |
| CZ300532B6 (en) | 2009-06-10 |
| WO1999015528A1 (en) | 1999-04-01 |
| TW576836B (en) | 2004-02-21 |
| DK1017696T3 (en) | 2002-07-08 |
| CA2304722A1 (en) | 1999-04-01 |
| AU741434B2 (en) | 2001-11-29 |
| HUP0003686A3 (en) | 2003-04-28 |
| PL193321B1 (en) | 2007-01-31 |
| PT1017696E (en) | 2002-09-30 |
| MXPA00002658A (en) | 2004-03-10 |
| NO20001465L (en) | 2000-03-21 |
| ES2174490T3 (en) | 2002-11-01 |
| IL134787A (en) | 2007-05-15 |
| EP1017696A1 (en) | 2000-07-12 |
| NZ503459A (en) | 2001-12-21 |
| NO20001465D0 (en) | 2000-03-21 |
| JP2001517669A (en) | 2001-10-09 |
| CA2304722C (en) | 2005-11-22 |
| PL339516A1 (en) | 2000-12-18 |
| EP1017696B1 (en) | 2002-03-20 |
| IL134787A0 (en) | 2001-04-30 |
| TR200000653T2 (en) | 2000-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300251I1 (en) | Thienyl, furyl, pyrrolyl and biphenyl sulfonamides and derivatives for modulating endothelin activity. | |
| ES2058351T3 (en) | A PROCEDURE FOR PRODUCING A SUSTAINED RELEASE FORMULATION THAT IS SUITABLE FOR HUMAN AND VETERINARY USE. | |
| DE69727262D1 (en) | Slow release bioactive substance preparation with an acidic group | |
| DE58906659D1 (en) | Stabilizing organopolysiloxane compositions which are crosslinkable with the elimination of alcohols to give elastomers. | |
| DE69023574D1 (en) | Amphoteric compositions and polymer forms of alpha-hydroxy acids, and their therapeutic use. | |
| ATE62899T1 (en) | HETEROAROMATIC ACIDS SUBSTITUTED BY ETHINYL WITH RETINOSAEUR-LIKE ACTIVITY. | |
| RU94028109A (en) | NEW SUBSTITUTED SALICYL ACIDS, METHOD OF THEIR RECEIVING | |
| AR005147A1 (en) | AN INJECTABLE AQUEOUS PHARMACEUTICAL SOLUTION INCLUDING DANOFLOXACIN OR ONE OF ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND ITS USE. | |
| PT1124893E (en) | POLYISOCYANATE POLYADIC PRODUCTS | |
| KR910000703A (en) | Antagonists of Tetrazol Stimulating Amino Acid Receptors | |
| ID26296A (en) | SALT ADDITION OF ALORALOID MORPHIN AND ITS USE | |
| CA2313878A1 (en) | Composition for suppressing behavior problems of pets | |
| ES2082514T3 (en) | DERIVATIVES OF FLUOROALIFATIC DIMERIC ACIDS AND THEIR USE. | |
| KR900011470A (en) | External preparation | |
| FI923968A0 (en) | HETEROCYCLISKT SUBSTITUERADE KINOLYLMETOXIFENYLACETAMIDER. | |
| BR0013730A (en) | Stabilization of wooden substrates | |
| MY128486A (en) | Acid addition salts of morphine alkaloids and the use thereof | |
| SE8304331D0 (en) | PHARMACEUTICAL WITH ANALGETIC EFFECT | |
| KR890003741A (en) | 7- (1-pyrrolidinyl) quinolonecarboxylic acid derivative | |
| RU95118723A (en) | OIL-IN-WATER EMULSION STABILIZER, COSMETIC AND / OR DERMATOLOGICAL EMULSION, SKIN TREATMENT METHOD | |
| TH21862A (en) | Treatment of dermatitis | |
| NO180086C (en) | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |